Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Motor Activity 126Breast Neoplasms 78Neoplasms 48Prostatic Neoplasms 19Fatigue 16Obesity 14Colorectal Neoplasms 13Lung Neoplasms 11Polycystic Ovary Syndrome 10Colonic Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Weight Loss 6Ovarian Neoplasms 6Rectal Neoplasms 5Multiple Myeloma 5Lymphedema 5Leukemia 5Inflammation 5Pancreatic Neoplasms 4Overweight 4Multiple Endocrine Neoplasia Type 1 4Lymphoma 4Leukemia, Myeloid, Acute 4Insulin Resistance 4Depression 4Cognitive Dysfunction 4Brain Neoplasms 4Stomach Neoplasms 3Peripheral Nervous System Diseases 3

Interventions

Carboplatin 87Paclitaxel 77Bevacizumab 38Topotecan 23liposomal doxorubicin 22Gemcitabine 22Taxes 21Cisplatin 17Drug Therapy 14Docetaxel 14Cyclophosphamide 14pembrolizumab 13Immunoglobulin G 12Disulfides 12veliparib 8rucaparib 8mirvetuximab soravtansine 8niraparib 7Albumin-Bound Paclitaxel 7sargramostim 6Filgrastim 6Erlotinib Hydrochloride 6Doxorubicin 6pazopanib 5Granulocyte-Macrophage Colony-Stimulating Factor 5Chemotherapy, Adjuvant 5CP protocol 5trebananib 4temsirolimus 4olaparib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Fallopian Tube Neoplasms × Exercise × Clear all
NCT05047926 2025-08-08

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Mayo Clinic

Phase NA Completed
90 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03685695 2021-09-02

Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Roswell Park Cancer Institute

Phase 2 Completed
9 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡